Atlas Trials

Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care

Clinical trial NCT01163916 · COMPLETED

Trial details

NCT number
NCT01163916
Sponsor
Abbott
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis
Start date
2008-01-01
Primary completion
2011-11-01
Enrollment
252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.